Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma
2021-07-22 09:27
AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA
2021-07-21 21:02
Hyundai Mobis develops the world's first 'brainwaves' based ADAS technology
2021-07-21 21:00
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 (Alrizomadlin) Granted an Orphan Drug Designation by the FDA for the Treatment of Stage IIB-IV Melanoma, Marking the Twelfth Obtained by the Company
2021-07-21 18:37
Clarivate Introduces Cortellis Supply Chain Network™, a Revolutionary Digital Partnering Solution
2021-07-21 16:05
Synthetic Biology Startup Allozymes Raises US $5 Million Seed Round to Deliver Sustainable, Scalable Manufacturing of Natural Ingredients
2021-07-21 07:18
Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome
2021-07-21 05:44
ExoFlo™ From Direct Biologics Fulfills Urgent Medical Need in COVID-19 Treatment
2021-07-21 03:43
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology
2021-07-20 23:00
Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology
2021-07-20 22:54
Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer
2021-07-20 21:53
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy
2021-07-20 20:00
Everest Medicines Announces Strategic Collaboration with MediTrust Health Co., Ltd to Develop Novel Payment Solutions for Patients in China
2021-07-20 18:42
GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership
2021-07-20 18:00
Novotech Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
2021-07-20 13:10
Juventas Cell Therapy Ltd. Closes Series C Financing to Advance the "Rapid Commercialization and Internationalization" Development Strategy
2021-07-20 10:47
deCODE genetics - New study on inheritance and fetal growth
2021-07-19 23:00
RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib
2021-07-19 19:21
A Drop for Clear Vision: Japan Has Surpassed Itself Again with the Development of Ultra-High-Concentration Lutein
2021-07-19 18:27
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE
2021-07-19 09:00
1
232
233
234
235
236
451